CLINICAL_TRIALS trial_result · 2016-11-17

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma [Phase 2]

A Phase 2 study evaluating the efficacy and safety of MEDI-563 in adults with uncontrolled asthma has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2016-11-17